Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0001209191-21-065892

Options or other derivatives

  • Director acquired 27,860 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lee Frank D. Director 2021-11-17 Grant or award · Stock Option (Right to Buy) +27,860 27,860 D
Loading xslF345X03/doc4.xml…